Glendon E. French III - May 20, 2021 Form 4/A - Amendment Insider Report for Pulmonx Corp (LUNG)

Signature
/s/ Lauren Cristina, Attorney-in-Fact for Glendon E. French
Stock symbol
LUNG
Transactions as of
May 20, 2021
Transactions value $
-$1,026,780
Form type
4/A - Amendment
Date filed
12/3/2021, 06:08 PM
Date Of Original Report
May 21, 2021
Previous filing
Dec 3, 2021
Next filing
Jun 11, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LUNG Common Stock Options Exercise $22K +10K +0.8% $2.20* 1.26M May 20, 2021 Direct
transaction LUNG Common Stock Sale -$207K -5.06K -0.4% $41.01 1.25M May 20, 2021 Direct F1, F2
transaction LUNG Common Stock Sale -$841K -19.9K -1.59% $42.19 1.23M May 20, 2021 Direct F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LUNG Stock Option (Right to Buy) Options Exercise $0 -10K -5.41% $0.00 175K May 20, 2021 Common Stock 10K $2.20 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2020.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.71 to $41.25, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.85 to $42.70, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F4 The shares subject to the option are immediately exercisable and vest in 48 equal monthly installments beginning on August 28, 2020, subject to the Reporting Person's continuous service through each such vesting date.

Remarks:

This amendment is filed to correct the inadvertent omission of the option exercise transaction and the amount of securities beneficially owned following the reported transactions in columns 9 and 5 of each of the reported row in Table II and Table I, respectively. The error in columns 9 and 5 also appears in subsequent Forms 4 filed through November 22, 2021.